Alseres Pharmaceuticals Inc /De Sample Contracts

PURCHASE AGREEMENT ------------------
Purchase Agreement • March 17th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
AutoNDA by SimpleDocs
EXHIBIT 10.5 REGISTRATION RIGHTS AGREEMENT -----------------------------
Registration Rights Agreement • September 27th, 1999 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
AND
License Agreement • January 4th, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
Form of Warrant to Purchase --------------------------- Common Stock ------------
Boston Life Sciences Inc /De • March 12th, 2002 • Pharmaceutical preparations • Massachusetts
RECITALS
Note Purchase Agreement • May 3rd, 2007 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
WITNESSETH ----------
Registration Rights Agreement • March 12th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations
and
Rights Agreement • September 13th, 2001 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York
RECITALS
Purchase Agreement • June 9th, 2000 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
SECTION 1. ----------
Boston Life Sciences Inc /De • March 17th, 1999 • Pharmaceutical preparations • New York
Warrant for the Purchase of Shares of Common Stock
Boston Life Sciences Inc /De • July 30th, 2002 • Pharmaceutical preparations • Massachusetts
RECITALS
Employment Agreement • July 17th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
EXCLUSIVE LICENSE AGREEMENT BETWEEN
Exclusive License Agreement • August 14th, 2006 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Massachusetts
AutoNDA by SimpleDocs
Exhibit 99.4 SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT This SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT (the "Addendum") is made and entered into as of March 12, 2003, by and among Boston Life Sciences, Inc., a Delaware corporation (the...
Registration Rights Agreement • March 13th, 2003 • Boston Life Sciences Inc /De • Pharmaceutical preparations

This SECOND ADDENDUM TO REGISTRATION RIGHTS AGREEMENT (the "Addendum") is made and entered into as of March 12, 2003, by and among Boston Life Sciences, Inc., a Delaware corporation (the "Company") and each of the purchasers set forth on the execution page hereof (the "Purchasers"). This Addendum supplements that certain Registration Rights Agreement, dated as of July 25, 2002, by and among the Company and the Initial Holders (as defined therein), as supplemented by the First Addendum thereto dated as of November 22, 2002 (the "Registration Rights Agreement"). Capitalized terms not defined herein shall have the meanings given to them in the Registration Rights Agreement.

REGISTRATION RIGHTS AGREEMENT
Registration Rights Agreement • December 16th, 2003 • Boston Life Sciences Inc /De • Pharmaceutical preparations • New York

This Agreement is being entered into pursuant to the Preferred Stock and Warrant Purchase Agreement, dated as of the date hereof, by and among the Company and the Purchasers (the “Purchase Agreement”).

EXHIBIT 10.2 AMENDED AND RESTATED PROMISSORY NOTE
Boston Life Sciences Inc /De • February 13th, 2007 • Pharmaceutical preparations • Massachusetts
PLACEMENT AGENT COMMON STOCK PURCHASE WARRANT To Purchase Shares of Common Stock of BOSTON LIFE SCIENCES, INC.
Boston Life Sciences Inc /De • December 16th, 2003 • Pharmaceutical preparations • New York

THIS IS TO CERTIFY THAT , or registered assigns (the “Holder”), is entitled, during the Exercise Period (as hereinafter defined), to purchase from Boston Life Sciences, Inc., a Delaware corporation (the “Company”), the Warrant Stock (as hereinafter defined and subject to adjustment as provided herein), in whole or in part, at a purchase price of $1.49 per share, all on and subject to the terms and conditions hereinafter set forth.

Exhibit 10.15 THIS AGREEMENT made in duplicate as of this 9th day of August, 2000. BETWEEN:
Confidential Treatment Requested • August 9th, 2002 • Boston Life Sciences Inc /De • Pharmaceutical preparations • Ontario
SECURITIES PURCHASE AGREEMENT
Securities Purchase Agreement • March 31st, 2009 • Alseres Pharmaceuticals Inc /De • Pharmaceutical preparations • Delaware

The selling stockholders may from time to time pledge or grant a security interest in some or all of the shares of common stock owned by them and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the shares of common stock from time to time under this prospectus after we have filed a supplement to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act of 1933 supplementing or amending the list of selling stockholders to include the pledgee, transferee or other successors in interest as selling stockholders under this prospectus.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!